Indivior (INDV) RNS Announcements

Add to Alert list
Date Time Source Announcement
11 Mar 2016 02:02 PM
RNS
Directorate Change
22 Feb 2016 03:41 PM
RNS
Director/PDMR Shareholding
22 Feb 2016 10:22 AM
RNS
Holding(s) in Company
18 Feb 2016 07:00 AM
RNS
Preliminary Full Year Results Announcement
15 Feb 2016 10:00 AM
RNS
Holding(s) in Company
11 Feb 2016 09:17 AM
RNS
Paragraph IV Notification
09 Feb 2016 04:34 PM
RNS
Holding(s) in Company
03 Feb 2016 07:00 AM
RNS
Notification of Full Year Results
24 Dec 2015 09:44 AM
RNS
Holding(s) in Company
21 Dec 2015 04:26 PM
RNS
Holding(s) in Company
09 Dec 2015 04:29 PM
RNS
Holding(s) in Company
09 Dec 2015 12:45 PM
RNS
R&D Day & Preliminary Financial Guidance 2016
07 Dec 2015 07:00 AM
RNS
Repurchase of $75m debt
02 Dec 2015 01:28 PM
RNS
Holding(s) in Company
01 Dec 2015 02:03 PM
RNS
Director/PDMR Shareholding
01 Dec 2015 08:43 AM
RNS
Holding(s) in Company
24 Nov 2015 04:55 PM
RNS
FDA does not approve Naloxone Nasal Spray
04 Nov 2015 03:31 PM
RNS
Director/PDMR Shareholding
03 Nov 2015 12:00 PM
RNS
3rd Quarter Results
30 Oct 2015 03:08 PM
RNS
Director/PDMR Shareholding
29 Oct 2015 08:42 AM
RNS
Holding(s) in Company
28 Oct 2015 09:41 AM
RNS
Q3 Conference Call on Tuesday, November 3 2015
19 Oct 2015 02:07 PM
RNS
Holding(s) in Company
12 Oct 2015 07:00 AM
RNS
Response to Court's decision on motion to amend
09 Oct 2015 12:00 PM
RNS
2015 Interim Dividend - Conversion Rate
06 Oct 2015 10:05 AM
RNS
Holding(s) in Company
05 Oct 2015 10:00 AM
RNS
Paragraph IV Notification
01 Oct 2015 09:54 AM
RNS
Director/PDMR Shareholding
25 Sep 2015 04:40 PM
RNS
Paragraph IV Notification
24 Sep 2015 09:56 AM
RNS
Director/PDMR Shareholding
08 Sep 2015 02:30 PM
RNS
Indivior PLC Research & Development Day Details
08 Sep 2015 09:20 AM
RNS
Holding(s) in Company
28 Aug 2015 09:22 AM
RNS
Holding(s) in Company
28 Aug 2015 09:15 AM
RNS
Holding(s) in Company
28 Aug 2015 09:11 AM
RNS
Holding(s) in Company
05 Aug 2015 11:44 AM
RNS
Holding(s) in Company
29 Jul 2015 07:01 AM
RNS
FDA Grants Naloxone Nasal Spray Priority Review
29 Jul 2015 07:01 AM
RNS
Half Yearly Financial Results
27 Jul 2015 10:11 AM
RNS
Holding(s) in Company
24 Jul 2015 09:41 AM
RNS
Holding(s) in Company
15 Jul 2015 01:00 PM
RNS
Notification of Half Year Results
14 Jul 2015 09:08 AM
RNS
Holding(s) in Company
03 Jul 2015 02:47 PM
RNS
Replacement Director/PDMR Shareholding
01 Jul 2015 11:28 AM
RNS
Director/PDMR Shareholding
01 Jul 2015 08:56 AM
RNS
Response to '832 Patent Case and will Appeal
01 Jul 2015 08:54 AM
RNS
New Trial Date for Patent Infringment Lawsuit
17 Jun 2015 04:06 PM
RNS
Director/PDMR Shareholding
14 May 2015 07:00 AM
RNS
Result of AGM
13 May 2015 12:20 PM
RNS
Director/PDMR Shareholding
13 May 2015 12:18 PM
RNS
Director/PDMR Shareholding

Indivior is a pharmaceutical company that develops and sells treatments for addiction and other serious mental illnesses.

Founded in 1994 as a division of Reckitt Benckiser and demerged in 2014, Indivior is listed on the London Stock Exchange and the NASDAQ Global Select Market.

Indivior share price is listed in London under the ticker INDV.

UK 100